• ARCA Cy5 EGFP mRNA (5-moUTP) Workflows

  2026-08-29

  Build a dual-readout workflow that separates mRNA delivery and localization from protein translation in mammalian cells. Use the Cy5 signal to evaluate uptake and trafficking, then use EGFP expression to compare functional delivery systems such as carbohydrate-decorated nanoparticles.

• N-Formimidoyl Thienamycin: 1982 Antibacterial Study

  2026-08-28

  Cullmann and colleagues compared N-formimidoyl thienamycin with several contemporary β-lactam antibiotics across resistant clinical isolates and combined MIC testing with bactericidal and β-lactamase-related analyses. The study showed unusually broad gram-negative activity, especially against Pseudomonas aeruginosa and Acinetobacter spp., while also defining important species-specific limitations relative to cefotaxime and moxalactam.

• Cinoxacin In Vitro: Spectrum, Methods, and Resistance

  2026-08-28

  Lumish and Norden’s reference study established a systematic in vitro profile of Cinoxacin against clinical aerobic gram-negative isolates, combining MIC testing, disk diffusion, bactericidal assays, and serial-passage resistance experiments. Its findings defined strong activity against common urinary pathogens while identifying poor activity against Pseudomonas aeruginosa and gram-positive organisms and a substantial capacity for resistance selection.

• ADAMTS9-AS1, miR-587, and Ferroptosis in EOC

  2026-08-27

  The reference study identifies an ADAMTS9-AS1/miR-587/SLC7A11 regulatory axis that suppresses ferroptosis in epithelial ovarian cancer cells. Its combination of RNA perturbation, rescue experiments, and target-validation assays provides a mechanistic framework for linking non-coding RNA regulation with ferroptotic vulnerability in ovarian cancer.

• Doxycycline hyclate for BBB Research

  2026-08-27

  Doxycycline hyclate provides a practical way to interrogate MMP-2/MMP-9-driven blood-brain barrier injury, with a published mouse workflow linking intervention to tight-junction preservation and cognitive outcomes. This guide translates that evidence into assay design, formulation controls, cross-domain applications, and troubleshooting strategies for neurovascular and infection research.

• Amyloid β-Peptide (1-42): Applied Workflows

  2026-08-26

  Build reproducible Aβ42 models by separating peptide preparation, aggregation state, and biological readout. This workflow connects neuronal toxicity and ion-channel studies with a microglial clearance assay inspired by P2Y2 receptor biology.

• GI 254023X: Designing Better ADAM10 Assays

  2026-08-26

  GI 254023X is a selective ADAM10 inhibitor for separating proximal sheddase activity from downstream signaling and barrier phenotypes. This article combines ADAM10 biology with assay-design lessons from partial BACE inhibition to improve exposure, selectivity, and interpretation in preclinical models.

• Atorvastatin: From Mevalonate to Ferroptosis

  2026-08-25

  Atorvastatin is more than an HMG-CoA reductase inhibitor: it is a versatile probe for connecting cholesterol metabolism, vascular remodeling, and ferroptosis. This guide translates recent hepatocellular carcinoma findings into practical assay and model-selection decisions.

• Minocycline HCl as a Microglial Test of Translation

  2026-08-25

  Minocycline HCl can do more than suppress inflammation: used carefully, it can reveal whether microglial activity is required for stimulus-driven amyloid clearance. This translational perspective connects the 40-Hz retinal flicker findings with rigorous reagent selection, assay design, and development strategy.

• HMGB1 and Early Diabetic Nephropathy: Proteomic Evidence

  2026-08-24

  This iScience study combines quantitative serum proteomics, Mfuzz trajectory clustering, and WGCNA to identify proteins associated with diabetic nephropathy progression. HMGB1 was prioritized as a potential early-monitoring biomarker and was further supported by cell and animal experiments performed under high-glucose conditions, although prospective clinical validation remains necessary.

• CENPO, Prognosis, and Immunity in Lung Adenocarcinoma

  2026-08-24

  This study identifies CENPO as a superenhancer-associated oncogenic factor linked to poor prognosis, immune dysregulation, and aggressive behavior in lung adenocarcinoma. By integrating TCGA and GEO analyses with chromatin visualization and cell-based validation, it proposes the CENPO-associated prognostic signature as a potentially useful framework for risk stratification and mechanistic studies.

• Wnt agonist 1 in Wnt–GPX4 Assay Design

  2026-08-23

  Wnt agonist 1 (BML-284) offers a defined pharmacological input for studying β-catenin–TCF signaling and its possible relationship to GPX4-linked platinum resistance. This article focuses on causal assay design, evidence boundaries, and translational limitations rather than repeating a standard activation protocol.

• 40-Hz Flicker and Retinal Amyloid Clearance

  2026-08-22

  A 2026 mouse study reports that 40-Hz light flicker enhances retinal amyloid-β clearance through regulation of MHC-II-positive microglia. The work connects sensory stimulation with immune-mediated waste removal and uses minocycline inhibition to test whether microglial activity is required for improved retinal function.

• Tetracycline: From Ribosome Tool to Translation

  2026-08-21

  Tetracycline is more than a routine antibiotic selection reagent. This thought-leadership article examines its ribosomal mechanism, experimental value, translational boundaries, and strategic use alongside mechanistic cancer research such as LKB1-driven senescence in lung adenocarcinoma.

• Fingolimod and the Next Frontier of Immune Trafficking

  2026-08-20

  Fingolimod (FTY720) offers translational researchers more than an established multiple sclerosis mechanism: it is a controlled perturbation of lymphocyte positioning. When considered alongside magnetic bispecific nano-antibody platforms for in vivo CAR-T-mimicking cell generation, its value lies in helping researchers separate immune-cell availability, tumor infiltration, and per-cell antitumor function.

8424 records 1/562 page Next 12345 下5页 Last page